What question did this study set out to answer?

This research aims to understand how FTY720 treatment affects immunity and can lead to reactivated cryptococcosis in previously infected mice.

May 2, 2026

Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment.

View Full Paper

Ask AI

Bookmark

Authors

MYMichiko YoshidaTohoku University KSKo SatoTohoku University NNNana NakahataTohoku University

Discussion

Member takes

Implication

Randomized trial investigates reactivated cryptococcosis risk in persistently infected mice following FTY720 treatment, suggesting preventive strategies are needed.

Key Points

This research aims to understand how FTY720 treatment affects immunity and can lead to reactivated cryptococcosis in previously infected mice.
Animal model using persistently infected mice
Assessment of Th1 immunity effects post-FTY720 treatment
Analysis of immunological mechanisms triggering disease reactivation
FTY720 treatment leads to impairment of Th1-mediated immunity.
Highlighting potential risks of reactivated cryptococcosis in patients with subclinical infections.

Cite This Study

Yoshida et al. (2026) studied this question.

synapsesocial.com/papers/69f5945c71405d493afff1de https://doi.org/10.1128/iai.00612-25

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial investigates reactivated cryptococcosis risk in persistently infected mice following FTY720 treatment, suggesting preventive strategies are needed.

Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment.

Discussion

Member takes

Implication

Key Points

Cite This Study

Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider